B6C3F1 mouse hepatocytes (TRL)

  • B6C3F1 mouse hepatocytes
  • High viability (>80%)
  • Characterized for Phase I/II drug-metabolizing enzyme activity

B6C3F1 mouse hepatocytes are isolated by Triangle Research Laboratories (now part of Lonza) and characterized for viability, plateability (adherence to a collagen-coated surface), and general Phase I and Phase II drug metabolizing enzyme activities.

Suspension qualified cryopreserved mouse hepatocytes have post-thaw viabilities over 80%.

Plateable cryopreserved mouse hepatocytes have post-thaw viabilities over 80%. Each lot can also be plated in a collagen-coated plate or similar. These lots are guaranteed to maintain a healthy monolayer (>85% confluency) for a minimum of 3 days in culture.

Ordering information

Westburg offers this product in The Netherlands, Belgium, Luxembourg,
If you are not located in these countries please visit the Lonza website to find your local distributor.
Cat no. Description
LO MXCP01 Cryo Mouse (B6C3F1) Hpctyes, Pltable Q:
LO MXCS01 Cryo Mouse (B6C3F1) Hpctyes, Suspn Q: